Skip to main content
. 2022 Oct 7;12:16885. doi: 10.1038/s41598-022-21506-8

Figure 4.

Figure 4

Anti-tumor efficacy of vaccinia VG9/(SST-14)2-HSA in nude mice bearing U-2 OS tumor cells. (AD) Tumor volumes in nude mice treated with PBS (A), VG9 (B), VG9/TK (C), VG9/(SST-14)2-HSA (D). (E) Average tumor volumes of mice received virotherapy (n = 5). *p < 0.05. (F) Kaplan-Meier survival curves of tumor-bearing nude mice treated with vaccinia viruses. **p < 0.01.